Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious, debilitating disorder with a wide spectrum of symptoms, including fatigue, pain, depression and neurocognitive deterioration. Over 17 million people around the world have ME/CFS, predominantly women with peak onset at 30–50 years. Given the wide spectrum of symptoms and unclear etiology, specific biomarkers for diagnosis and stratification of ME/CFS are lacking. Here the results from PET/SPECT/MRI/fMRI studies are reviewed to understand the pathophysiology and to develop therapies of this severe syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abu-Judeh HH, Levine S, Kumar M et al (1998) Comparison of SPET brain perfusion and 18F-FDG brain metabolism in patients with chronic fatigue syndrome. Nucl Med Commun 19:1065–1071
Ashburner J, Friston KJ (2000) Voxel-based morphometry—the methods. Neuroimage 11(6 Pt 1):805–821
Bakheit AMO, Behan PO, Dinan TG et al (1992) Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br Med J 304:1010–1012
Barnden LR, Shan ZY, Staines DR et al (2018) Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome. Neuroimage Clin 20:102–109
Bested AC, Marshall LM (2015) Review of myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health 30:223–249
Boissoneault J, Letzen J, Lai S et al (2018) Static and dynamic functional connectivity in patients with chronic fatigue syndrome: use of arterial spin labelling fMRI. Clin Physiol Funct Imaging 38:128–137
Buchwald D, Cheney PR, Peterson DL et al (1992) A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 116:103–113
Carruthers BM, Jain AK, De Meirleir KL et al (2003) Myalgic encephalitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 11:107–116
Carruthers BM, van de Sande MI, De Meirleir KL et al (2011) Myalgic encephalomyelitis: international consensus criteria. J Intern Med 270:327–338
Cleare AJ, Messa C, Rabiner EA et al (2005) Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biol Psychiatry 57:239–246
Cope H, David AS (1996) Neuroimaging in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 60:471–473
Cope H, Pernet A, Kendall B et al (1995) Cognitive functioning and magnetic resonance imaging in chronic fatigue. Br J Psychiatry 167:86–94
Costa DC, Tannock C, Brostoff J (1995) Brainstem perfusion is impaired in chronic fatigue syndrome. Q J Med 88:767–773
de Lange FP, Kalkman JS, Bleijenberg G et al (2004) Neural correlates of the chronic fatigue syndrome—an fMRI study. Brain 127(Pt 9):1948–1957
de Lange FP, Kalkman JS, Bleijenberg G et al (2005) Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 26:777–781
de Lange FP, Koers A, Kalkman JS et al (2008) Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain 131(Pt 8):2172–2180
Eguchi A, Fukuda S, Kuratsune H et al (2020) Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun 84:106–114
Fischler B, D’Haenen H, Cluydts R et al (1996) Comparison of 99mTc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 34:175–183
Fukuda K, Straus SE, Hickie I et al (1994) Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121:953–959
Fukuda S, Nojima J, Motoki Y et al (2016a) A potential biomarker for fatigue: oxidative stress and anti-oxidative activity. Biol Psychol 118:88–93
Fukuda S, Nojima J, Kajimoto O et al (2016b) Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome. Biofactors 42:431–440
Gay CW, Robinson ME, Lai S et al (2016) Abnormal resting-state functional connectivity in patients with chronic fatigue syndrome: results of seed and data-driven analyses. Brain Connect 6:48–56
Ichise M, Salit IE, Abbey SE et al (1992) Assessment of regional cerebral perfusion by 99mTc-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 13:767–772
Institute of Medicine of the National Academies (2015) Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. The National Academy Press, Washington, DC
Jason L, Torres-Hardings SR, Jurgens A et al (2004) Comparing the Fukuda et al. criteria and the Canadian case definition for chronic fatigue syndrome. J Chronic Fatigue Syndr 12:37–52
Kanai Y, Hasegawa S, Kimura Y et al (2007) N-isopropyl-4-[123I]iodoamphetamine (123I-IMP) products: a difference in radiochemical purity, unmetabolized fraction, and octanol extraction fraction in arterial blood and regional brain uptake in rats. Ann Nucl Med 2:387–391
Klimas NG, Broderick G, Fletcher MA (2012) Biomarkers for chronic fatigue. Brain Behav Immun 26:1202–1210
Kuratsune H, Yamaguti K, Lindh G et al (2002) Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage 17:1256–1265
Lange G, DeLuca J, Maldjian JA et al (1999) Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 171:3–7
Lange G, Steffener J, Cook DB et al (2005) Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 26:513–524
Lewis DH, Mayberg HS, Fischer ME et al (2001) Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT. Radiology 219:766–773
Lynch S, Seth R, Montgomery S (1991) Antidepressant therapy in the chronic fatigue syndrome. Br J Gen Pract 41:339–342
Machale SM, Lawrie SM, Cavanagh JTO et al (2000) Cerebral perfusion in chronic fatigue syndrome and depression. Br J Psychiatry 176:550–556
McCann UD, Szabo Z, Scheffel U et al (1998) Positron emission tomographic evidence of toxic effect of MDMA (“ecstasy”) on brain serotonin neurons in human beings. Lancet 352:1433–1437
Mizuno K, Tanaka K, Tanabe HC et al (2015) Less efficient and costly processes of frontal cortex in childhood chronic fatigue syndrome. Neuroimage Clin 9:355–368
Nakatomi Y, Mizuno K, Ishii A et al (2014) Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study. J Nucl Med 55:945–950
Narita M, Nishigami N, Narita N et al (2003) Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 311:264–266
Natelson BH, Weaver SA, Iseng CL et al (2005) Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diagn Lab Immunol 12:52–55
Okada T, Tanaka M, Kuratsune H et al (2004) Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 4:14
Peterson PJ, Sirr SA, Grammith FC et al (1994) Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin Diagn Lab Immunol 1:222–226
Reeves WC, Wagner D, Nisenbaum R et al (2005) Chronic fatigue syndrome—a clinically empirical approach to its definition and study. BMC Med 3:19
Sahbai S, Kauv P, Abrivard M et al (2019) Severe posterior hypometabolism but normal perfusion in a patient with chronic fatigue syndrome/myalgic encephalomyelitis revealed by PET/MRI. Eur J Nucl Med Mol Imaging 46:531–532
Schmaling KB, Lewis DH, Fiedelak JI et al (2003) Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome. Psychosom Med 65:129–136
Schwartz RB, Garada BM, Komaroff AL et al (1994a) Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. AJR Am J Roentgenol 162:935–941
Schwartz RB, Komaroff AL, Garada BM et al (1994b) SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. AJR Am J Roentgenol 162:943–951
Shan ZY, Finegan K, Bhuta S et al (2018) Decreased connectivity and increased blood oxygenation level dependent complexity in the default mode network in individuals with chronic fatigue syndrome. Brain Connect 8:33–39
Siessmeier T, Nix WA, Schreckenberger M (2003) Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 74:922–928
Simpsom HB, Lombardo I, Slifstein M et al (2003) Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [11C]McN 5652. Biol Psychiatry 54:1414–1421
Tanaka M, Watanabe Y (2010) A new hypothesis of chronic fatigue syndrome: co-conditioning theory. Med Hypotheses 75:244–249
Tanaka M, Sadato N, Okada T et al (2006) Reduced responsiveness is an essential feature of chronic fatigue syndrome: a fMRI study. BMC Neurol 6:9
Tanaka M, Mizuno K, Tajima S et al (2009) Central nervous system fatigue alters autonomic nerve activity. Life Sci 84:235–239
Tanaka M, Ishii A, Watanabe Y (2013) Neural mechanisms underlying chronic fatigue. Rev Neurosci 24:617–628
Tanaka M, Tajima S, Mizuno K et al (2015) Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. J Physiol Sci 65:483–498
Tirelli U, Chierichetti F, Tavio M et al (1998) Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 105:54S–58S
Tomoda A, Miike T, Yamada E et al (2000) Chronic fatigue syndrome in childhood. Brain Dev 22:60–64
Vercoulen JHMM, Swanink CMA, Zitman FG et al (1996) Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347:858–861
Watanabe Y, Evengard B, Natelson BH, Jason L, Kuratsune H (eds) (2008) Fatigue science for human health. Springer, Tokyo, Berlin, Heidelberg, New York
Watanabe Y, Kajimoto O, Kuratsune H (2012) Biochemical indices of fatigue for anti-fatigue strategies and products. In: Matthews G et al (eds) The handbook of operator fatigue. Ashgate Publishing Limited, Great Britain, pp 209–224
Wojcik W, Armstrong D, Kanaan R (2011) Chronic fatigue syndrome: labels, meanings and consequences. J Psychosom Res 70:500–504
Yamamoto S, Ouchi Y, Onoe H et al (2004) Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport 15:2571–2574
Yamano E, Sugimoto A, Hirayama A et al (2016) Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci Rep 6:34990
Acknowledgements
The author thanks Prof. Andor W. J. M. Glaudemans of Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, for his great advice from the previous version of the chapter ‘PET and SPECT Studies in the Chronic Fatigue Syndrome/Myalgic Encephalomyelitis’. The author also thanks all collaborators Drs. Hirohiko Kuratsune, Kouzi Yamaguti, Yasuhito Nakatomi, Sanae Fukuda, Masaaki Tanaka, Akira Ishii, Kei Mizuno, Emi Yamano, Yoshihito Shigihara, Seiki Tajima, Kayo Takahashi, Yasuhiro Wada, Kayo Onoe, Yoko Nagatomo, Shigeyuki Yamamoto, Hirotaka Onoe, Yasuomi Ouchi, Hideo Tsukada, Norihiro Sadato, Tomohisa Okada, Bengt Langstrom and Birgitta Evengard for their great contribution. This research was supported by AMED under Grant Number JP20ak0101059.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Watanabe, Y. (2021). PET/SPECT/MRI/fMRI Studies in the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. In: Dierckx, R.A., Otte, A., de Vries, E.F.J., van Waarde, A., Sommer, I.E. (eds) PET and SPECT in Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-57231-0_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-57231-0_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57230-3
Online ISBN: 978-3-030-57231-0
eBook Packages: MedicineMedicine (R0)